IFNA1 and major depressive disorder: Several key features of IFN-related neurotoxicity are shared – depression and fatigue are the most common behavioral symptoms and occur in up to 70% of patients while rarer symptoms such as mania, seizures, and psychosis occur in less than 5% (112, 115).